Delivery Order 75F40123D00021-75F40126F19037
Award Date 9/30/26
Potential Completion Date 9/29/27
Potential Value $4.1M
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Competitive 8(a)
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration issued a delivery order to Kaiva Strategies, LLC on August 17, 2026, under the Professional, Administrative, and Consulting Services (PACS) IDIQ, a competitive 8(a) set-aside contract with a ceiling value of $132,365. Kaiva Strategies is a tribally-owned, minority-owned small business. The order supports facilities support services for the FDA's Human Foods Program and is performed on a labor-hours pricing basis. Place of performance is Ivins, UT. Work...
- The Food and Drug Administration issued a delivery order to Kaiva Strategies, LLC on September 30, 2025, under the Professional, Administrative, and Consulting Services (PACS) IDIQ for budget and acquisition liaison support to the FDA's Office of Finance, Budget, and Acquisitions. The order is valued at $15.5 million on a labor-hour basis and was issued as a competitive 8(a) set-aside. Kaiva Strategies is a tribally-owned, minority-owned small business holding 8(a) joint venture, HUBZone, and...
- The Food and Drug Administration issued a $712,661.72 delivery order to Kaiva Strategies, LLC on September 30, 2026, under the Professional, Administrative, and Consulting Services (PACS) IDIQ, a Competitive 8(a) vehicle, for regulatory review support. Kaiva Strategies is a tribally-owned, minority-owned 8(a) small business. Place of performance is Berwyn Heights, Maryland. The order is firm fixed price with an ultimate completion date of September 29, 2027. The PACS IDIQ is a single-award...
- The Food and Drug Administration issued a $283,809.72 delivery order to Kaiva Strategies, LLC on August 3, 2026, under the Competitive 8(a) Professional, Administrative, and Consulting Services (PACS) IDIQ for Project Manager III and Consultant VIII support to advance conformity assessment expansion and enhancement for medical devices. Kaiva Strategies is a tribally-owned, minority-owned 8(a) small business. Place of performance is Ivins, UT. The order runs through December 2, 2027 on a firm...
- The Food and Drug Administration issued a delivery order to Kaiva Strategies, LLC, a tribally-owned, minority-owned 8(a) small business, on September 21, 2026, with a ceiling value of $249,848.74 for technical documentation support for drug manufacturing quality assurance. The order is issued under the Professional, Administrative, and Consulting Services (PACS) IDIQ, a $100 million Competitive 8(a) single-award vehicle running through August 2028. Place of performance is Ivins, UT. The order...
- The Food and Drug Administration issued a delivery order to Kaiva Strategies, LLC, a tribally-owned, minority-owned 8(a) small business, on September 30, 2025, with a ceiling value of $2,750,333.99 under the Professional, Administrative, and Consulting Services (PACS) IDIQ for correspondence analyst, public health program specialist, and management and program analyst services to the Office of the Commissioner. The order is competitive 8(a) set-aside and covers a one-year base period under a...
- The Food and Drug Administration issued a $2.23 million delivery order to Kaiva Strategies, LLC, a tribally-owned, minority-owned 8(a) small business, on August 27, 2026, under the Competitive 8(a) Professional, Administrative, and Consulting Services (PACS) IDIQ. The order is a two-year firm-fixed-price hybrid task order providing professional and technical support services to FDA's Office of Policy and Office of Product Evaluation and Quality within the Center for Devices and Radiological...
- The Food and Drug Administration (FDA) awarded a firm fixed price delivery order valued at $73,547.61 to Kaiva Strategies, LLC on February 25, 2026, with an ultimate completion date of September 1, 2026. This award is issued under the Professional, Administrative, and Consulting Services (PACS) Indefinite Delivery Indefinite Quantity (IDIQ) contract and carries a competitive 8(a) set-aside designation. The delivery order supports the Office of Integrated Food Safety System Partnerships,...
- The Food and Drug Administration (FDA) awarded a three-year task order to Kaiva Strategies, LLC for research and policy support services under the Professional, Administrative, and Consulting Services (PACS) Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle. The task order, effective through September 17, 2028, carries a ceiling value of $941,896.32 and was awarded on a labor-hours basis without a set-aside designation. Kaiva Strategies, a tribally-owned, minority-owned small...
- The Food and Drug Administration issued a delivery order to Kaiva Strategies, LLC, a tribally-owned, minority-owned 8(a) small business joint venture, on July 29, 2026, with a ceiling value of $2.76 million under the Competitive 8(a) Professional, Administrative, and Consulting Services (PACS) IDIQ. The order is set aside for 8(a) competition. The PACS IDIQ is a $100 million competitive 8(a) single-award vehicle running through August 2028, providing professional, administrative, and...